Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Facebook Inc. Stock Will Survive the Fake News Era

Facebook is investing heavily in the same technologies as larger rivals as it fights the problem of fake news.

Alphabet Inc’s Google Is Still Growing, But Where Is It Going?

Google remains a powerful company, but continued growth means pushing into businesses currently dominated by powerful competitors like Amazon and Apple.

Why Adobe Systems Incorporated Stock Is Still a Top-Notch Tech Play

Adobe (ADBE) stock is fundamentally the Nvidia of software, as it is able to turn graphics analysis into action in a heartbeat.

Even Intel Corporation Is Lifted by the Rising Tide

Analysts are hoping Intel can earn 89 cents for the quarter ending in December, making INTC stock appear a bargain in a rising market.

Is Tesla Inc Stock the Biggest Winner After the Latest Trump Bailout?

Tesla (TSLA) stock looks like the biggest winner in the solar tariff, as other U.S. companies are either broke or importing panels from China.

Advanced Micro Devices Inc. Stock Still Is on the Chip Sector Battlefield

AMD faces a surging Nvidia in graphics, and the same problems as Intel with the Spectre flaw. The present looks brighter than the future.

Is Sanofi’s Bioverative Inc Buyout Just the Start?

Bioverativ and Juno Therapeutics both drew buyout bids as drug companies seek to use CAR-T therapy against cancer profitably.

Where Is Blockchain Heading? Your Questions Answered

No one really knows where blockchain is heading, including experts. Look for companies with second-mover advantage to find the most success.

Is International Business Machines Corp. Stock Still Worth a Look?

IBM stock remains dependent on its mainframe monopoly, as results in cloud, analytics and services disappointed in its quarterly report.

Celgene Corporation Stock Needs More Than a Juno Acquisition to Thrive

Celgene faces big risks in buying cancer drug candidates. The drug may fail late tests, or it might not get its price past insurers.